This story was originally published on CFO.com. To receive daily news and insights, subscribe to our free daily CFO.com newsletter. Adam Elinoff | Agilent Technologies Adam Elinoff was appointed chief financial officer of scientific instruments maker Agilent Technologies, effective Nov. 17. Elinoff joins Agilent from biotechnology company Amgen, where he has held leadership roles for a total of 19 years, most recently as vice president of finance and treasurer. Elinoff was previously the regional CFO for E ...

站在新的历史起点，皖仪科技将继续秉持"客户导向、奋斗为本、正直诚信、严谨开放"的核心价值观， 以新园区为创新基地，以企业发展战略为指引，在精密科学仪器和生命健康领域不断突破。 （编辑 张明富） 图 为：皖仪科技总部新园区 皖仪科技供图 皖仪科技董事长、总经理臧牧表示，新园区将成为皖仪科技发展的坚实底座，助力公司乘风破浪，成就 行业领先地位。 本报讯 （记者徐一鸣）今年适逢安徽皖仪科技股份有限公司（以下简称"皖仪科技"）成立22周年。近 日，皖仪科技又迎来研发新大楼落成、新园区启用的重要里程碑，不仅标志着企业硬件设施的全面升 级，更象征着皖仪科技在精密科学仪器和生命健康领域迈入全新发展阶段。 ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 传统光谱分析是否正困扰着您？——功能单一、数据割裂、难以原位、操作繁琐。 会议日程： | O 14:00 -- 14:10 | 智能高端光谱检测仪器是什么样的? -- 谱光 | 任祺君 | 常州谱光慧联科技有限公司 总经理 | | --- | --- | --- | --- | | | 慧联的智慧光谱之路 | | | | ○ 14:10 -- 14:40 | 二维半导体微腔激子极化激元的多维光谱表征 | 张龙 | 厦门大学 教授 | | 0 14:40 -- 15:10 | Excipolar Trion - AI深度融合的智能化多维综合 | 孙天池 | 常州谱光慧联科技有限公司 光学工程师 | | | 光谱分析平台 | | | | ○ 15:10--15:15 | 第一轮抽奖 | 主持人 | | | 0 15:15 -- 15:45 | Excipolar Spinon - 智能化超快动力学瞬态吸收 | 曹佳炜 | 常州谱光慧联科技有限公司 光学工程师 | | | 光谱平台 | | | | ...

Group 1 - Thermo Fisher Scientific Inc. is recognized as a strong long-term low volatility stock, with a Buy rating reiterated by Bank of America Securities analyst Michael Ryskin [1] - The company announced plans to expand its growth strategy through collaboration with OpenAI, aiming to enhance drug development speed and cost-effectiveness [2] - The collaboration with OpenAI focuses on accelerating scientific innovation, improving productivity, and simplifying operations by integrating OpenAI APIs into various business areas [3] Group 2 - Thermo Fisher Scientific provides a range of analytical instruments, reagents, equipment, software, and services across multiple segments, including Analytical Instruments and Life Sciences Solutions [4]

Group 1 - The article highlights the rise of Anhui Wanyi Technology Co., Ltd. as a key player in the domestic scientific instrument industry, emphasizing its commitment to independent innovation since its establishment in 2003 [2] - Wanyi Technology has evolved from a startup focused on industrial airtightness testing to a comprehensive national high-tech enterprise covering industrial testing, laboratory analysis instruments, online monitoring, and medical instruments [2] - The company aims to break foreign technology monopolies and promote the localization of high-end analytical instruments in China, with a focus on smart industry, environmental monitoring, laboratory analysis, and healthcare [2] Group 2 - A significant milestone for Wanyi Technology is the upcoming inauguration of its new R&D building on October 28, 2025, which represents a strategic leap in the company's development [2] - The new facility will feature modern R&D offices, intelligent production workshops, and advanced digital exhibition halls, showcasing the company's commitment to innovation and technological advancement [2] - Wanyi Technology is hosting a grand ceremony titled "Instrument Spirit, New Journey" to celebrate this milestone, inviting industry peers, partners, and the public to participate online [2] Group 3 - The article describes an immersive online experience for attendees to explore Wanyi Technology's new campus, including a digital exhibition hall, modern office areas, and intelligent production workshops [9] - This event provides a unique opportunity to witness the meticulous craftsmanship behind high-end scientific instruments and the reality of Chinese manufacturing [9]

Core Viewpoint - The article highlights that Zeyou Technology has been recognized as one of the "Little Giant" enterprises in Anhui Province due to its innovation capabilities and market leadership in the high-end scientific instrument sector [2][3]. Group 1: Company Recognition - On October 20, Anhui Province's Economic and Information Technology Department announced the seventh batch of specialized and innovative "Little Giant" enterprises, with Zeyou Technology being selected for its outstanding innovation and core technology advantages [2][3]. - This recognition is seen as a validation of Zeyou Technology's commitment to independent research and development, as well as its focus on niche markets [3]. Group 2: Company Profile - Zeyou Technology is a high-tech company with complete independent intellectual property rights, specializing in precision instruments such as scanning electron microscopes, in-situ measurement systems, step height gauges, and electron beam lithography machines [4]. - The company plays a significant role in filling gaps in the national scientific precision instrument sector [4].

Core Insights - Conestoga Capital Advisors reported that equity markets reached new all-time highs in Q3 2025, but their Small Cap Composite underperformed the Russell 2000 Growth Index, returning -1.4% compared to the Index's 12.2% gain [1] - The gains in the Index were primarily driven by low-quality stocks, particularly unprofitable, high-beta names [1] Company Performance - Novanta Inc. (NASDAQ:NOVT) experienced a one-month return of -6.45% and a significant 39.50% decline in value over the past 52 weeks, closing at $105.56 per share with a market capitalization of $3.797 billion on October 17, 2025 [2] - The company reported revenue of $241 million in Q2 2025, reflecting a growth of 2% but a 2% decline in organic revenue [4] Market Sentiment - Novanta Inc.'s stock underperformed due to disappointing revenue growth and a cautious outlook for med-tech capital equipment, which negatively impacted investor sentiment [3] - The stock's performance was further affected by skepticism regarding near-term acceleration, despite some results beating EPS expectations [3] Hedge Fund Interest - Novanta Inc. was held by 27 hedge fund portfolios at the end of Q2 2025, a decrease from 31 in the previous quarter, indicating reduced interest among hedge funds [4] - While Novanta Inc. has potential as an investment, there is a belief that certain AI stocks may offer better upside potential with less downside risk [4]

Core Insights - Bruker Corporation has secured a $10 million order for advanced Nuclear Magnetic Resonance (NMR) instrumentation from notable research institutions, including the New York Structural Biology Center, the University of Delaware, and Northwestern University [1][2]. Group 1: Order Details - The $10 million order is aimed at enhancing research capabilities in drug discovery and disease biology [2]. - The advanced NMR instrumentation includes a fast NMR sample shuttle system, a magnetic tunnel, and an electromagnetic field cycling coil [2]. Group 2: Technical Capabilities - The NMR Relaxometry system allows for measurements of spin-lattice relaxation rate constants for various spins in biological macromolecules, including proteins and nucleic acids [3]. - The system operates across a range of magnetic fields from 100 µT to 16.4 T, facilitating advanced research [3]. Group 3: Research Implications - The new instrumentation is expected to open new time regimes for studying molecular dynamics, aiding in the understanding of biological processes and the discovery of potential new drugs for cancer and other diseases [4]. Group 4: Company Overview - Bruker Corporation specializes in developing, manufacturing, and distributing high-performance scientific instruments and analytical solutions across life sciences, applied sciences, and industrial applications [5]. - The company's product portfolio includes NMR spectrometers, mass spectrometry systems, atomic force microscopes, and preclinical imaging systems [5].

Core Insights - Douglas Lane & Associates has increased its investment in Thermo Fisher Scientific by purchasing 16,745 shares valued at approximately $7.79 million, bringing its total holdings to 216,276 shares [2][11] - Following this purchase, Thermo Fisher Scientific accounts for 1.5% of the fund's reportable assets under management as of September 30, 2025 [3] Company Overview - Thermo Fisher Scientific reported a total revenue of $43.21 billion and a net income of $6.58 billion for the trailing twelve months [4] - The company has a dividend yield of 0.32% and its stock price was $534.68 as of October 9, 2025, reflecting a 12% decline over the past year [3][4] Business Performance - Thermo Fisher achieved a 3% revenue growth to $10.9 billion in its fiscal second quarter, with a 6% year-over-year increase in diluted earnings per share (EPS) to $4.28 [13] - The company has raised its fiscal guidance for 2025 to approximately $44 billion in sales, up from $42.9 billion the previous year [14] Investment Rationale - The current price-to-earnings (P/E) ratio of Thermo Fisher is lower than it was a year ago, suggesting that the stock is more attractively valued now [12] - The combination of rising revenue, increasing EPS, and a reasonable P/E ratio positions Thermo Fisher stock as a compelling buy opportunity [14]

, /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, announced new file support from Wiley, a global leader in authoritative content and research intelligence, in their KnowItAll 2026 software release for raw NMR files. *subscription required About Wiley Wiley (NYSE: WLY) is a global leader in authoritat ...